So Bush's ES cell policy in the US will continue. Despite opposition from much of the scientific community, federally-funded scientists will only be able to work on older, less effective cell lines, grown using mouse 'feeder' cells and therefore unsuitable for use in humans at any stage. However, it wasn't all bad news for ES cell researchers after the election results came in last week. As an adjunct to the presidential election, on the California ballot was a proposition that would give $3 billion to fund ES cell research in California, the largest US state. This was passed by 59 percent of votes to 41 per cent - not necessarily surprising if the weight of the 'yes' campaign is considered, both financially and in terms of popular figures who gave their support to the cause.What the Californian vote means is that Californian scientists will be able to conduct ES cell research on new cell lines, paid for by state funds, circumventing the limits placed on them by Bush. They will have new facilities, be overseen by a new agency and the annual budget for research in California ($295 million) is now more than 10 times that which the Bush administration (which revelled in the claim that he was the 'only president ever to give money for stem cell research') spends on ES cell research. All this is likely to make California, in time, a world leader in the field, and will encourage scientists and companies from other states to move there, meaning a 'brain drain' from the rest of the US working under Bush's restrictive policy.
California, a state that, despite a budget deficit, is taking the risk of welcoming a new and promising science, should be congratulated. Media reports say it will become a 'mecca' or 'epicentre' of research and the new policy could 're-create the gold rush'. Other US states are worried that their own stem cell projects will become eclipsed - Massachusetts in particular, as Harvard University tries to raise private money for its stem cell centre, and Advanced Cell Technology, a Massachusetts-based biotechnology company, has announced plans to set up shop in California. Others say that the sheer weight of dollars behind the California stem cell project will threaten Britain and other nation's 'global lead' in stem cell research. None of this really matters - it can only be a good thing for California to become a world leader in this science. The more world leaders, the better, as the closer we might get to practical applications in people currently living with incurable conditions.
Dr Kirsty Horsey is Contributing Editor at BioNews. She is coeditor of Human Fertilisation and Embryology: Reproducing Regulation (buy this book from Amazon UK or Amazon USA) and coauthor of Tort Law (buy this book from Amazon UK or Amazon USA) and Skills For Law Students (buy this book from Amazon UK or Amazon USA).
